IMC Chicago’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
10,800
-47,700
-82% -$11.9M ﹤0.01% 2393
2025
Q4
$14.1M Buy
58,500
+34,000
+139% +$8.7M 0.01% 1011
2025
Q3
$6.71M Buy
24,500
+700
+3% +$191K ﹤0.01% 1379
2025
Q2
$6.14M Sell
23,800
-11,400
-32% -$2.72M ﹤0.01% 1268
2025
Q1
$7.88M Buy
35,200
+2,100
+6% +$490K ﹤0.01% 991
2024
Q4
$7.57M Sell
33,100
-31,400
-49% -$7.56M ﹤0.01% 1050
2024
Q3
$15.7M Sell
64,500
-1,700
-3% -$380K 0.01% 638
2024
Q2
$12.7M Buy
66,200
+15,400
+30% +$3.12M 0.01% 693
2024
Q1
$10.1M Buy
+50,800
New +$9.31M 0.01% 703

Other funds holding RMD

IMC Chicago's RMD Position: Q3 2024 in Review

IMC Chicago sold out of ResMed (RMD) in Q3 2024, closing a stake of 16,977 shares — an estimated $3.79M sold.

IMC Chicago first reported a position in RMD in Q2 2024 and held it in 1 quarter. The position peaked at $3.25M in Q2 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • IMC Chicago reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • IMC Chicago sold 16,977 ResMed shares in Q3 2024, an estimated $3.79M.
  • IMC Chicago first reported a position in ResMed in Q2 2024 and held it in 1 quarter.
  • IMC Chicago's ResMed position peaked at $3.25M in Q2 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on IMC Chicago's 13F filing for Q3 2024, filed 25 Oct 2024.